B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SGK2

MOLECULAR TARGET

serum/glucocorticoid regulated kinase 2

NCBI Gene: 101102 compounds

SGK2 (serum/glucocorticoid regulated kinase 2) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SGK2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1hydroxyfasudil [Supplementary Concept]0.691
2sp6001250.691

About SGK2 as a Drug Target

SGK2 (serum/glucocorticoid regulated kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented SGK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SGK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.